Literature DB >> 5437627

An improved method of digitoxin therapy.

R W Jelliffe, J Buell, R Kalaba, R Sridhar, R Rockwell, J G Wagner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5437627     DOI: 10.7326/0003-4819-72-4-453

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies.

Authors:  R W Jelliffe; T Iglesias; A K Hurst; K A Foo; J Rodriguez
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 3.  Drug prescribing in renal failure.

Authors:  W M Bennett
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

4.  Measuring digoxin.

Authors: 
Journal:  Br Med J       Date:  1970-08-22

5.  Production, recognition and treatment of digitalis intoxication.

Authors:  A Selzer; K E Cohn
Journal:  Calif Med       Date:  1970-10

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Principles of drug therapy in patients with renal disease.

Authors:  W M Bennett
Journal:  West J Med       Date:  1975-11

8.  Metabolism of digitoxin in man and its modification by spironolactone.

Authors:  K E Wirth; J C Frölich; J W Hollifield; F C Falkner; B S Sweetman; J A Oates
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

9.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

Authors:  J H Caldwell; C A Bush; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.